H. Khalil, Muhammad and O. Abdullah, Fuad (2024) Synthesis, characterisation, and anticancer and antioxidant activities of novel complexes of palladium and an organic Schiff-base ligand. Bulletin of the Chemical Society of Ethiopia, 38 (3). pp. 605-613. ISSN 1726-801X
Text (Research Article)
ajol-file-journals_120_articles_266816_65f015b368ba3.pdf - Published Version Download (346kB) |
Abstract
Treatment of the Schiff base 2-N-(salicylidene) benzothiazole (SabtH) with palladium chloride afforded the neutral 2-N-(salicylidene) benzothiazole palladium(II) complex. This was then treated with one molar equivalent of either ethylenediamine or 1,10-phenanthroline, yielding the neutral mixed ligand complexes 1 and 2, respectively. The prepared organic ligand and its mixed ligand complexes were characterised via UV-Vis, FTIR, 1H-NMR, and 13C-NMR spectroscopy. The antiproliferative activities of 1 and 2 were tested against MCF-7 (breast) and HT-29 (colon) cancer cells using an MTT assay. 1 showed strong antiproliferative activity against both MCF-7 and HT-29 cancer cells, with IC50 values of 74.6 ± 8.35 and 174 ± 20.28 µg/mL, respectively. In addition, 2 exhibited the maximum antioxidant activity, with an EC50 value of 1029 ± 196.76 µg/mL.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 2-N-(Salicylidene) benzothiazole 1,10-Phenanthroline Palladium mixed ligand complexes Anticancer Antioxidant activity |
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica R Medicine > RT Nursing |
Depositing User: | ePrints deposit |
Date Deposited: | 28 Aug 2024 13:39 |
Last Modified: | 28 Aug 2024 13:39 |
URI: | http://eprints.tiu.edu.iq/id/eprint/1521 |
Actions (login required)
View Item |